Literature DB >> 22204322

Current research on opioid receptor function.

Yuan Feng1, Xiaozhou He, Yilin Yang, Dongman Chao, Lawrence H Lazarus, Ying Xia.   

Abstract

The use of opioid analgesics has a long history in clinical settings, although the comprehensive action of opioid receptors is still less understood. Nonetheless, recent studies have generated fresh insights into opioid receptor-mediated functions and their underlying mechanisms. Three major opioid receptors (μ-opioid receptor, MOR; δ-opioid receptor, DOR; and κ-opioid receptor, KOR) have been cloned in many species. Each opioid receptor is functionally sub-classified into several pharmacological subtypes, although, specific gene corresponding each of these receptor subtypes is still unidentified as only a single gene has been isolated for each opioid receptor. In addition to pain modulation and addiction, opioid receptors are widely involved in various physiological and pathophysiological activities, including the regulation of membrane ionic homeostasis, cell proliferation, emotional response, epileptic seizures, immune function, feeding, obesity, respiratory and cardiovascular control as well as some neurodegenerative disorders. In some species, they play an essential role in hibernation. One of the most exciting findings of the past decade is the opioid-receptor, especially DOR, mediated neuroprotection and cardioprotection. The upregulation of DOR expression and DOR activation increase the neuronal tolerance to hypoxic/ischemic stress. The DOR signal triggers (depending on stress duration and severity) different mechanisms at multiple levels to preserve neuronal survival, including the stabilization of homeostasis and increased pro-survival signaling (e.g., PKC-ERK-Bcl 2) and antioxidative capacity. In the heart, PKC and KATP channels are involved in the opioid receptor-mediated cardioprotection. The DOR-mediated neuroprotection and cardioprotection have the potential to significantly alter the clinical pharmacology in terms of prevention and treatment of life-threatening conditions like stroke and myocardial infarction. The main purpose of this article is to review the recent work done on opioids and their receptor functions. It shall provide an informative reference for better understanding the opioid system and further elucidation of the opioid receptor function from a physiological and pharmacological point of view.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22204322      PMCID: PMC3371376          DOI: 10.2174/138945012799201612

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  307 in total

1.  Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in mouse brain.

Authors:  C Abbadie; Y-X Pan; G W Pasternak
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

2.  Primary structure of human beta-lipotropin.

Authors:  C H Li; D Chung
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

3.  delta2 opioid receptor agonist facilitates mean arterial pressure recovery after hemorrhage in conscious rats.

Authors:  Shawna M McBride; Joan Smith-Sonneborn; Peter Oeltgen; Francis W Flynn
Journal:  Shock       Date:  2005-03       Impact factor: 3.454

4.  Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys.

Authors:  S S Negus; M B Gatch; N K Mello; X Zhang; K Rice
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

5.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

6.  Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex.

Authors:  L Hackler; J E Zadina; L J Ge; A J Kastin
Journal:  Peptides       Date:  1997       Impact factor: 3.750

7.  Stress-induced analgesia in mu-opioid receptor knockout mice reveals normal function of the delta-opioid receptor system.

Authors:  C J LaBuda; I Sora; G R Uhl; P N Fuchs
Journal:  Brain Res       Date:  2000-06-30       Impact factor: 3.252

8.  The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.

Authors:  F Simonin; K Befort; C Gavériaux-Ruff; H Matthes; V Nappey; B Lannes; G Micheletti; B Kieffer
Journal:  Mol Pharmacol       Date:  1994-12       Impact factor: 4.436

9.  Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.

Authors:  Hiroaki Yamada; Naohito Shimoyama; Ichiro Sora; George R Uhl; Yasuichiro Fukuda; Hideshige Moriya; Megumi Shimoyama
Journal:  Brain Res       Date:  2006-03-10       Impact factor: 3.252

10.  A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia.

Authors:  H P Adams; C P Olinger; W G Barsan; M J Butler; N R Graff-Radford; T G Brott; J Biller; H Damasio; T Tomsick; M Goldberg
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

View more
  72 in total

1.  Neuroprotection by the kappa-opioid receptor agonist, BRL52537, is mediated via up-regulating phosphorylated signal transducer and activator of transcription-3 in cerebral ischemia/reperfusion injury in rats.

Authors:  Shudong Fang; Hui Xu; Junrui Lu; Yesen Zhu; Hong Jiang
Journal:  Neurochem Res       Date:  2013-08-31       Impact factor: 3.996

2.  In vivo neuronal co-expression of mu and delta opioid receptors uncovers new therapeutic perspectives.

Authors:  Eric Erbs; Lauren Faget; Pierre Veinante; Brigitte L Kieffer; Dominique Massotte
Journal:  Receptors Clin Investig       Date:  2014-09

Review 3.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

4.  Modulation of opioid-induced feeding behavior by endogenous nitric oxide in neonatal layer-type chicks.

Authors:  Samad Alimohammadi; Morteza Zendehdel; Vahab Babapour
Journal:  Vet Res Commun       Date:  2015-02-13       Impact factor: 2.459

5.  The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.

Authors:  Shou-Pu Yi; Qing-Hong Kong; Yu-Lei Li; Chen-Ling Pan; Jie Yu; Ben-Qiang Cui; Ying-Fei Wang; Guan-Lin Wang; Pei-Lan Zhou; Li-Li Wang; Ze-Hui Gong; Rui-Bin Su; Yue-Hai Shen; Gang Yu; Kwen-Jen Chang
Journal:  Acta Pharmacol Sin       Date:  2017-05-15       Impact factor: 6.150

6.  Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias.

Authors:  Nicole M Kennedy; Cullen L Schmid; Nicolette C Ross; Kimberly M Lovell; Zhizhou Yue; Yen Ting Chen; Michael D Cameron; Laura M Bohn; Thomas D Bannister
Journal:  J Med Chem       Date:  2018-09-24       Impact factor: 7.446

Review 7.  In vivo opioid receptor heteromerization: where do we stand?

Authors:  D Massotte
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 8.  The role of δ-opioid receptors in learning and memory underlying the development of addiction.

Authors:  Paul Klenowski; Michael Morgan; Selena E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Role of DOR-β-arrestin1-Bcl2 signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis.

Authors:  Pi-Qi Zhou; Heng Fan; Hui Hu; Qing Tang; Xing-Xing Liu; Li-Juan Zhang; Min Zhong; Zhe-Xing Shou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-12-06

Review 10.  Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.

Authors:  Bradley Nash; Olimpia Meucci
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.